Chemotherapy With Rituximab for Aggressive B-NHL in Children and Adolescents — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Chemotherapy With Rituximab for Aggressive B-NHL in Children and Adolescents — Stella

Home/Mature B-cell Non-Hodgkin Lymphoma/

View on ClinicalTrials.gov

Recruiting

Back to Mature B-cell Non-Hodgkin Lymphoma trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

China

Shanghai Children's Medical Center, Shanghai, Shanghai Municipality

Key details

Phase

Safety & dosing / Large-scale testing

Sponsor

Children's Cancer Group, China

Collaborators

Shanghai Children's Medical Center, Nanjing Children's Hospital

Enrollment target

~87 participants

Started

July 2025

Primary completion

June 2030

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.